ID   USP-13-Med
AC   CVCL_4U90
SY   USP-13-MED
DR   Wikidata; Q54991925
RX   PubMed=26358937;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Doubling time: 24.5 hours (PubMed=26358937).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26358937).
CC   Omics: CNV analysis.
CC   Omics: Transcriptome analysis by microarray.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
RX   PubMed=26358937; DOI=10.1007/s10616-015-9914-5; PMCID=PMC4960201;
RA   da Silva P.B.G., Rodini C.O., Kaid C., Nakahata A.M., Pereira M.C.L.,
RA   Matushita H., da Costa S.S., Okamoto O.K.;
RT   "Establishment of a novel human medulloblastoma cell line
RT   characterized by highly aggressive stem-like cells.";
RL   Cytotechnology 68:1545-1560(2016).
//
RX   PubMed=27498314; DOI=10.1016/j.jbiotec.2016.07.028;
RA   Ivanov D.P., Coyle B., Walker D.A., Grabowska A.M.;
RT   "In vitro models of medulloblastoma: choosing the right tool for the
RT   job.";
RL   J. Biotechnol. 236:10-25(2016).
//
RX   PubMed=27812533; DOI=10.1016/j.dib.2016.10.004; PMCID=PMC5079239;
RA   Ivanov D.P., Walker D.A., Coyle B., Grabowska A.M.;
RT   "Data on the number and frequency of scientific literature citations
RT   for established medulloblastoma cell lines.";
RL   Data Brief 9:696-698(2016).
//